Explore the words cloud of the AllerScreening project. It provides you a very rough idea of what is the project "AllerScreening" about.
The following table provides information about the project.
Coordinator |
UNIVERSIDAD POLITECNICA DE MADRID
Organization address contact info |
Coordinator Country | Spain [ES] |
Project website | http://www.aller-screening.upm.es/index.php/en/home |
Total cost | 4˙669˙300 € |
EC max contribution | 4˙669˙300 € (100%) |
Programme |
1. H2020-EU.2.1.1.1. (A new generation of components and systems: Engineering of advanced embedded and energy and resource efficient components and systems) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies) |
Code Call | H2020-NMBP-X-KET-2017 |
Funding Scheme | RIA |
Starting year | 2017 |
Duration (year-month-day) | from 2017-10-01 to 2021-09-30 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | UNIVERSIDAD POLITECNICA DE MADRID | ES (MADRID) | coordinator | 1˙182˙250.00 |
2 | CONSULTING QUIMICO SANITARIO S.L. | ES (COMENAR VIEJO MARDID) | participant | 807˙625.00 |
3 | BIO OPTICAL DETECTION SL | ES (MEJORADA DEL CAMPO (MADRID)) | participant | 675˙513.00 |
4 | MICROFLUIDIC CHIPSHOP GMBH | DE (JENA) | participant | 520˙000.00 |
5 | SERVICIO ANDALUZ DE SALUD | ES (SEVILLA) | participant | 438˙125.00 |
6 | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN | DE (MUENCHEN) | participant | 289˙000.00 |
7 | UNIVERSITEIT ANTWERPEN | BE (ANTWERPEN) | participant | 289˙000.00 |
8 | MEDIZINISCHE UNIVERSITAET WIEN | AT (WIEN) | participant | 171˙217.00 |
9 | CONSEJERIA DE SALUD y FAMILIAS DE LA JUNTA DE ANDALUCIA | ES (Sevilla) | participant | 154˙693.00 |
10 | CLINICA SAN CARLO CASA DI CURA PRIVATA POLISPECIALISTICA SPA | IT (PADERNO) | participant | 141˙875.00 |
Food allergy is an immune-based disease that has become an important public health problem that affects children and adults and may be increasing in prevalence.In the US, food allergy affects 5% of children under the age of 5 years and 4% of teens and adults, and its prevalence appears to be on the increase. Globally, it is estimated that over 6% of the population, around 200 to 250 million people, suffer from some food allergies, affecting more than 17 million people only in Europe.
The main objective of this proposal is translating an optical diagnostic technology already proven in which the novel AllerScreening platform is based on, to the clinical routine, addressing a priority healthcare unmet need from the laboratory to the clinic. The unique features of AllerScreening will allow clinicians to early detect main food allergies (at least the 90% of European food allergies) through a simple test using a drop of sera, reducing the cost and technical requirements of the current clinical practice. This new and innovative cost-effective sensing system for the in vitro component diagnosis of food allergies will be feasible thanks to the multiplexed disposable BioKits and the optical Pont-of-Care (PoC) reader in which the novel AllerScreening platform is based on, allowing the adoption of a novel PoC diagnostic device specific for food allergies.
Project public website | Websites, patent fillings, videos etc. | 2020-04-09 01:27:03 |
Initial dissemination plan | Documents, reports | 2020-04-09 01:27:03 |
Handbook on management | Documents, reports | 2020-04-09 01:27:03 |
Take a look to the deliverables list in detail: detailed list of AllerScreening deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2018 |
MarÃa Garrido-Arandia, Bruno Cuevas-ZuvirÃa, Araceli DÃaz-Perales, Luis Pacios A Comparative Study of Human Saposins published pages: 422, ISSN: 1420-3049, DOI: 10.3390/molecules23020422 |
Molecules 23/2 | 2020-04-09 |
2019 |
Maria J. Rodriguez, Javier Ramos-Soriano, James R. Perkins, Ainhoa Mascaraque, Maria J. Torres, Francisca Gomez, Araceli Diaz-Perales, Javier Rojo, Cristobalina Mayorga Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-40114-7 |
Scientific Reports 9/1 | 2020-04-09 |
2019 |
MarÃa Garrido-Arandia, Jaime Tome-Amat, Diego Pazos-Castro, Vanesa Esteban, Maria M Escribese, Guadalupe Hernández-RamÃrez, Alma Montalvo-Yuste, Domingo Barber,Luis F Pacios, Araceli DÃaz-Perales. Interaction of Alt a 1 with SLC22A17 in the airway mucosa (accepted for publicacion on March 18th 2019). published pages: , ISSN: 0105-4538, DOI: |
Allergy | 2020-04-09 |
2018 |
Rocio Espinosa, MarÃa Laguna, Fátima Fernández, Beatriz Santamaria, Francisco Sanza, Maria Maigler, Juan Ãlvarez-Millán, VÃctor Canalejas-Tejero, Miguel Holgado A Proof-of-Concept of Label-Free Biosensing System for Food Allergy Diagnostics in Biophotonic Sensing Cells: Performance Comparison with ImmunoCAP published pages: 2686, ISSN: 1424-8220, DOI: 10.3390/s18082686 |
Sensors 18/8 | 2020-04-09 |
2019 |
Bruno Cuevas-ZuvirÃa, MarÃa Garrido-Arandia, Araceli DÃaz-Perales, Luis Pacios Energy Landscapes of Ligand Motion Inside the Tunnel-Like Cavity of Lipid Transfer Proteins: The Case of the Pru p 3 Allergen published pages: 1432, ISSN: 1422-0067, DOI: 10.3390/ijms20061432 |
International Journal of Molecular Sciences 20/6 | 2020-04-09 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALLERSCREENING" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ALLERSCREENING" are provided by the European Opendata Portal: CORDIS opendata.